Also, we observed that CD3-CD56bright did not express CD85j (not shown) but that CD3-CD56dim cells from ccRCC patients exhibited higher frequencies of CD85j+ cells but with similar amounts of expression compared to HD (Figure 2I). This evidence concerns the gene LILRB1 and nonpapillary renal cell carcinoma.